View more in
Cancer

NanoString Technologies, Parker Institute for Cancer Immunotherapy Partner on Cell Therapy Project

GenomeWeb
 2021-06-15

NEW YORK – NanoString Technologies and the Parker Institute for Cancer Immunotherapy, or PICI, on Tuesday said they have partnered on a project to identify molecular features of cell therapies and improve their activity. Within the collaboration, Seattle-based NanoString will apply its molecular profiling technologies, specifically its nCounter Analysis System...

www.genomeweb.com

Comments / 0

Comments / 0